doi:10.1007/s12250-013-3331-8

[1]
Jian-lin Dou, Tao Jing, Jing-jing Fan, Zhi-ming Yuan, 2011: Surface Display of Domain Ⅲ of Japanese Encephalitis Virus E Protein on Salmonella Typhimurium by Using an Ice Nucleation Protein ^*, Virologica Sinica, 26, 409-417. doi: 10.1007/s12250-011-3216-7
[2]
Wenling Wang, Baoying Huang, Xiuping Wang, Wenjie Tan, Li Ruan, 2019: Improving Cross-Protection against Influenza Virus Using Recombinant Vaccinia Vaccine Expressing NP and M2 Ectodomain Tandem Repeats, Virologica Sinica, 34, 583-591. doi: 10.1007/s12250-019-00138-9
[3]
葛菲菲, 邱亚峰, 杨耀武, 陈溥言, 2005: High Level Expression of Major Antigenic Segment of Japanese Encephalitis Virus Strain SA 14-14-2 E Protein, Virologica Sinica, 20, 117-120.
[4]
曾明, 俞永新, 董关木, 范行良, 姚智慧, 李德富, 2002: Com plete Sequence Analysis of the Full-length Genom e of the Japanese Encephalitis Virus Attenuated Strain SA14-12-1-7, Virologica Sinica, 17, 206-210.
[5]
张明杰, 汪美先, 姜绍谆, 马文煜, 于碧云, 1989: A Rapid lgM Antibody Capture ELISA and its Employ in the Early Diagnosis of Japanese Encephalitis, Virologica Sinica, 4, 251-.
[6]
项秉懿, 陈苏民, 1993: Research Progress on Molecular Biology of Japanese Encephalitis Virus, Virologica Sinica, 8, 199-206.
[7]
张海林, 张云智, 黄文丽, 米竹青, 龚鹤琴, 王静林, 2001: Isolation of Japanese Encephalitis Virus from Brain Tissues of Bat in Yunnan Province, Virologica Sinica, 16, 74-77.
[8]
Wenyi Guan, Wendong Lan, Jing Zhang, Shan Zhao, Junxian Ou, Xiaowei Wu, Yuqian Yan, Jianguo Wu, Qiwei Zhang, 2020: COVID-19: Antiviral Agents, Antibody Development and Traditional Chinese Medicine, Virologica Sinica, 35, 685-698. doi: 10.1007/s12250-020-00297-0
[9]
Xi Liu, Li Ding, Jing Yuan, Jian Liao, Lian Duan, Wenfei Wang, Weiguo Tan, Weiye Yu, Boping Zhou, Xinchun Chen, Zheng Yang, 2019: Identification of a Novel Universal Potential Epitope on the Cytoplasmic Tail of H7N9 Virus Hemagglutinin, Virologica Sinica, 34, 334-337. doi: 10.1007/s12250-019-00110-7
[10]
张春涛, 李秀华, 宋爱京, 许四宏, 王佑春*, 2005: The Relationship of the Nucleic Acid and Antibody of HIV/HCV Among Drug Users, Virologica Sinica, 20, 600-602.
[11]
肖火根, 范怀忠, 1994: Cross-protection and its use on the control of plant virus disease, Virologica Sinica, 9, 1-.
[12]
肖火根, 范怀忠, 1995: Studies on the Mild Strain Cross-Protection of Papaya Ringspot Virus, Virologica Sinica, 10, 155-.
[13]
项秉懿, 杨勇峰, 刘利兵, 马文煜, 姜绍谆, 苏成芝, 1995: Chemical Synthesis of an Oligonucleotide Probe and Its Detection of JEV, Virologica Sinica, 10, 131-.
[14]
陈悦, 杨东亮, 郝连杰, 高学中, 刘立昆, 1995: Ana1ysis of the Components of Circulating Immune Complex in Epidemic Hemorrhagic Fever, Virologica Sinica, 10, 111-.
[15]
陈明明, 吴东, 袁丽, 陈新文, 胡志红料, 2003: Prokaryotic Expression of Three bro Genes from Helicoverpa armigera Singlenucleocapsid Nucleopolyhedrovirus and Generation of Antibodies, Virologica Sinica, 18, 597-602.
[16]
王雪鹏, 刘悦竹, 孙英峰, 常维山, , 2004: Studies on the Technique of the Diagnosis for Fowlpox Disease, Virologica Sinica, 19, 523-525.
[17]
刘超红, 焦成松, 陈新文, 2006: Cloning of HCV ns2 Gene and its Expression in Prokaryotic and Mammalian cells, Virologica Sinica, 21, 217-220.
[18]
李春英, 吕春兰, 喻东威, 张利平, 赛文, 吴秉仁, 2000: Study on Human Cytomegalovirus(HCMV)Infection in the Blood Donors, Virologica Sinica, 15, 111-115.
[19]
Huaqing Shu, Shuzhen Wang, Shunan Ruan, Yaxin Wang, Jiancheng Zhang, Yin Yuan, Hong Liu, Yongran Wu, Ruiting Li, Shangwen Pan, Yaqi Ouyang, Shiying Yuan, Peng Zhou, You Shang, 2020: Dynamic Changes of Antibodies to SARS-CoV-2 in COVID-19 Patients at Early Stage of Outbreak, Virologica Sinica, 35, 744-751. doi: 10.1007/s12250-020-00268-5
[20]
Xiaohui Zou, Shengrui Mu, Yeming Wang, Li Guo, Lili Ren, Xiaoyan Deng, Haibo Li, Jiankang Zhao, Yulin Zhang, Hui Li, Binghuai Lu, Chaolin Huang, Bin Cao, 2022: Characterization of two SARS-CoV-2 subgenomic RNA dynamics in severe COVID-19 patients, Virologica Sinica, 37, 30-37. doi: 10.1016/j.virs.2022.01.008